n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Respiratory Distress Syndrome in 1 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mochizuki, M | 1 |
| Ishii, Y | 1 |
| Itoh, K | 1 |
| Iizuka, T | 1 |
| Morishima, Y | 1 |
| Kimura, T | 1 |
| Kiwamoto, T | 1 |
| Matsuno, Y | 1 |
| Hegab, AE | 1 |
| Nomura, A | 1 |
| Sakamoto, T | 1 |
| Uchida, K | 1 |
| Yamamoto, M | 1 |
| Sekizawa, K | 1 |
1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury.
Topics: Animals; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dise | 2005 |